Graphite Bio, Inc. has entered into a Merger Agreement with Lenz Therapeutics, Inc., in which Merger Sub will merge with and into LENZ, with LENZ continuing as a wholly owned subsidiary of Graphite and the surviving corporation of the merger. The Mer
AI Assistant
LENZ THERAPEUTICS INC
2023
8 K
Find Answers
Ask about any part of the document to get insights, explanations, or key details.